THE ROLE OF HEPATOPROTECTORS IN THERAPY OF LIVER DISEASES


E.B. Grishchenko, M.I. Shchekina

Consultative and Diagnostic Centre CJSC " MEDSI Group of Companies ", Moscow
Until today, hepatoprotection occupies an important place in the treatment of liver diseases. The essential phospholipids (EPL) are widely used in chronic hepatitis of various origins, cirrhosis, fatty degeneration, and hepatic coma. Currently, gastroenterologists are increasingly focusing on drugs containing other compounds that increase hepatoprotective effect in addition to EPL. In this respect, the new combined hepatoprotectorHepaguard Active® containing L-carnitine, and vitamin E in adddition to EPL in one capsule, is of absolute interest.

About the Autors


E.B. Grishchenko – PhD in Medical Sciences, Consultative and Diagnostic Centre CJSC " MEDSI Group of Companies ", Moscow
M.I. Shchekina - PhD in Medical Sciences, Consultative and Diagnostic Centre CJSC " MEDSI Group of Companies ", Moscow


Similar Articles


Бионика Медиа